Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Portola Pharmaceuticals

A company developing therapeutics for the treatment of acute and chronic cardiovascular and autoimmune and inflammatory diseases

Overview Structured Data Issues Contributors Activity

portola.com

Is a

Organization

Company

Company attributes

Industry

Location

South San Francisco, California

B2X

B2B

CEO

‌

William Lis

AngelList URL

angel.co/portola-ph...maceuticals

Legal Name

Portola Pharmaceuticals, Inc.

Number of Employees (Ranges)

201 – 500

Full Address

270 East Grand Ave., South San Francisco, CA 94080, US

Investors

DUNS Number

142296016

Founded Date

2003

Total Funding Amount (USD)

89,000,000

Latest Funding Round Date

November 21, 2011

Stock Symbol

PTLA

Exchange

Nasdaq

Acquisition Transaction

Alexion Pharmaceuticals

Latest Funding Type

Series D

Patents Assigned (Count)

Wellfound ID

portola-pharmaceuticals

Other attributes

Company Operating Status

Closed

Public/Private

Public

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Portola Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API